Sean T. Smith
Analyst · Edwin Mok of Needham & Company
Thanks, Deno, and good morning, everyone. I'll provide a brief analysis of our financial results for the second quarter of fiscal year 2013, review our balance sheet and cash flows and then provide our outlook. Slides 5, 6 and 7 show our sequential IC and FPD revenue performance. As Deno mentioned, second quarter revenues totaled $106.7 million, which was within our guided range. Revenues for the quarter were muted by reduced high-end orders from one of our Asian foundry customers, due in part to a node migration for which we had not yet completed qualification. We had expected continued high-end orders for the 32-nanometer node, but actual orders did not match our projections. We do expect to begin to regain share after we are qualified for this technology node during Q3. In addition, we received one of our E-Beam 8000 a few weeks ago, and we believe we will able to extend our market share once this tool is qualified. The E-Beam 8000 is capable of producing photomasks down to 14 nanometers, and we will be the only merchant supplier in Asia, outside of Japan, to have this advanced litho tool. Revenues for IC and FPD photomasks were $82.2 million and $24.5 million, respectively, for the second quarter. Breaking out sales geographically: 56% of total sales were from Asia, 35% from North America and 9% from Europe. Even though we saw a decrease in high-end orders from the foundry customer we previously discussed, high-end IC sales increased sequentially, as Deno mentioned, to 31% to $23.4 million or 28% of our total IC sales for the quarter. Advanced FPD sales were $16.5 million, a sequential decrease of approximately 900k, primarily as a result to seasonality. Advanced FPD sales represented 67% of total FPD sales for the quarter. As a reminder, high-end IC revenues consist of revenue derived from semi-designed at and below 45 nanometers. High-end FPD revenues consist of revenue at and above G8, as well as AMOLED-based products. Gross margins for the second quarter was 23.2%, up sequentially by 210 basis points as a result of the increased sales. The incremental margin contribution was approximately 54% on the increased sales. Selling, general and administrative expenses for the second quarter were $12.2 million, up sequentially by $1.1 million. The increase was primarily attributable to increased health care costs and, to a lesser extent, sales-related expenses. As compared to Q2 2012, SG&A was essentially flat. R&D expenses, which consist principally of continued development for our global advanced process technologies and qualifications at advanced nodes, were $4.6 million, down approximately $300,000 sequentially. During the quarter, we generated operating income of $8.1 million or 7.6% of sales. The incremental margin contribution was approximately 42% on the increased sales. Noncash stock compensation for the quarter was approximately 900k. And EBITDA, as defined in our credit agreement for the quarter, was $28 million or $120 million on a trailing 12-month basis. Other income expense for the second quarter was expense of 900k, up 300k sequentially. During the second quarter, we recorded a tax provision of $1.7 million. And as Deno mentioned, GAAP net income was $4.9 million or $0.08 per diluted share. At the end of the second quarter, we had 1,290 full-time employees, this equates to revenue per employee of $331,000 on an annualized basis. Now turning to the balance sheet. Cash and cash equivalents at quarter end amounted to $211 million. And our net cash, which is cash less debt, was $31 million, down approximately $12 million sequentially. Our working capital at the end of the quarter was $207 million, down from $226 million from Q1, due primarily to increases in tool-related obligations. Accounts receivable increased to $83 million at quarter end, a sequential increase of $8 million, due primarily to increased revenue, principally high-end IC products. Accounts payable and accrued current liabilities at quarter end amounted to $104 million, and at the end of the quarter, we had $35 million of accrued CapEx. Please turn to Slide 9 as we review our capitalization. Total debt at quarter end was $180 million. The principal components of outstanding debt include: $22 million of the 5.5% senior convertible note, which is due in October of 2014; $115 million, 3.25% unsecured notes due April 2016; approximately $13 million for capital lease obligation; $23 million, 2.5% 5-year term loan related to the nanofab building; and approximately $7 million related to an expected 2% capital lease for one of the advanced e-beam tools. At the end of the quarter, we do not have any outstanding borrowings on our $30 million revolving credit line, which matures in April 2015. Taking a look at our cash flows. Cash provided by operations for the second quarter was approximately $17 million and $36 million year-to-date. Depreciation and amortization for the quarter was $18.3 million. Cash flow used in investing activities during the quarter amounted to $18 million and $35 million year-to-date. Year-to-date cash used in investing activities includes $32 million of cash CapEx. Net cash used by financing activities during the quarter amounted to $1 million and $7 million year-to-date. This includes $4 million related to the repurchase of shares of our majority-owned Taiwan subsidiary, PSMC. During the quarter, we announced our intent to acquire the remaining shares of PSMC through a tender offer. The transaction is expected to cost Photronics $25 million to $30 million, and the tender offer is expected to conclude on June 18, 2013. Please turn to Slide 10 as we take a look ahead. We expect our non-financed cash CapEx in 2013 to be in the range of $70 million and $90 million. And as Deno mentioned, we accelerated the installment of the 2 advanced e-beam litho systems for North America and Asia, one is being installed now and the other is scheduled for delivery next month. We accelerated the delivery of these tools as a result of projected high-end demand later this year in Q4 and into 2014. Payment terms for the non-financed portion of the tools are embedded in the $70 million to $90 million for 2013. As we discussed in the Q1 2013 Conference Call, we entered into a 5-year $32 million capital lease agreement for one of the advanced litho tools. We expect the majority of these - the majority of the lease to be recorded on the balance sheet in the third quarter of 2013 upon the acceptance of the tool. The lease is expected to carry a 2% interest rate. Currently, we plan to use our cash on hand for strategic initiatives, as well as reviewing opportunities in the future to reduce some of our higher-yielding outstanding debt. We do, however, have the flexibility to accelerate or decelerate our spend based upon market conditions. We expect to continue to generate free cash flow once again in 2013, and our investments are principally geared towards high-end, leading-edge products for IC and FPD applications. Our visibility, as always, continues to be limited, and our -- as our backlog is typically 1 to 2 weeks. We are projecting revenue for the third quarter of 2013 to be in the range of $107 million to $111 million. During 2013, our tax rate will be affected by the flow of income from jurisdictions, for which we have credits, and upon our limited ability to recognize tax benefits in areas which we are taxable. For the third quarter fiscal 2013, we expect tax expense to range -- be in the range of $2 million to $3 million. For fiscal 2013, we expect taxes will range from $10 million to $12 million. As a result, based upon our current operating model, we estimate EPS for the third quarter to be in the range of $0.08 to $0.11 per diluted share. Please turn to Slide 11. I'll leave you with a few key thoughts. We do expect to report top to bottom line improvement in Q3 and continue to anticipate further sequential improvement for the rest of the year. Looking into Q4 and into 2014, we expect accelerated high-end IC growth as we see continued opportunities in our customers' businesses and node-migration plans and believe that we are well positioned to become the leading global merchant photomask supplier as a result of our advanced technology, strategically deployed leading-edge capacity and strong financial position. We expect to benefit from increased high-end capacity in Boise and in Asia that matches it to our customer node-migration plans with our foundry customer, as well as capitalizing our Boise JV partner growth prospects in Asia. Now I'd like to turn the call over to the operator for questions and answers.